The website offers cash-price discounts on select medications. The White House announced the launch of TrumpRx, an online platform intended to provide lower cash prices on certain commonly…
Read MorePrescription Drugs
President Proposes Affordable Health Plan to Congress
Multiple avenues presented, the proposal seeks to lower costs and hold insurance companies accountable. President Donald Trump has announced the “Great Healthcare Plan,” which focuses on increasing healthcare…
Read More
Senate Committee Seeks FDA Safeguards on Abortion Pills
The legislators urge in-person dispensing of mifepristone, citing the black box warnings. Members of the Senate Committee on Health, Labor, Education, and Pensions are calling on the Food…
Read More
HHS and DEA Extend Telemedicine Prescribing Flexibilities Through 2026
Temporary extension maintains access to certain controlled medications. The Department of Health and Human Services (HHS), in coordination with the Drug Enforcement Administration (DEA), announced a fourth temporary…
Read More
President Trump Announces Lower Prescription Drug Pricing
The president has persuaded U.S.-based companies to take action. President Donald Trump recently struck a deal with nine U.S. pharmaceutical companies, which will decrease prices for a large…
Read More
President Signs Order Reclassifying Cannabis
The drug shifts from Class I to Schedule III, expanding potential for medical use. President Donald Trump signed an executive order Thursday that reclassifies cannabis as a Schedule…
Read More
House Members Write to HHS and FDA Regarding Mail-Order Abortion Drugs
A request from 175 House Members follows an earlier Senate letter on safety protocols and oversight. A group of 175 members of the U.S. House of Representatives, led…
Read More
CMS Launches Initiative to Control Drug Costs and Strengthen Medicaid Access
The new GENEROUS Model is intended to align Medicaid prescription prices with global standards. The Centers for Medicare & Medicaid Services (CMS) introduced a pilot program, the GENEROUS…
Read More
FDA Drafts New Guidance for the Development of Affordable Biosimilar Drugs
The new guidance seeks to lower development costs and improve patient access to safe, effective alternatives to high-cost biologic medicines. The U.S. Food and Drug Administration (FDA) recently…
Read More
President Announces Obesity Drug Deal with Pharmaceutical Companies
The most recent development would greatly reduce the cost under the president’s Most Favored Nation prescription drug pricing policy. President Donald Trump announced that a deal has been…
Read More